ATRCCongressional Stock Trades
AtriCure, Inc.
Surgical & Medical Instruments & Apparatus
Congressional stock trades in AtriCure, Inc. (ATRC) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
3
Politicians Trading
1
Last Traded
Sep 29, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr.D | Oct 12, 2026 | Sep 29, 2026 | Sell | $1,001 - $15,000 | +3.15% |
| Gilbert Ray Cisneros, Jr.D | Sep 10, 2026 | Aug 20, 2026 | Buy | $1,001 - $15,000 | +26.09% |
| Gilbert Ray Cisneros, Jr.D | Jun 6, 2025 | May 6, 2025 | Buy | $1,001 - $15,000 | +100.60% |
Price History
About AtriCure, Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
1 members of Congress have disclosed 3 trades in AtriCure, Inc. (ATRC). Most active: Gilbert Ray Cisneros, Jr. (3).
Across all disclosures, members of Congress reported 2 purchases and 1 sales of AtriCure, Inc. (ATRC). The most recent trade was on Sep 29, 2026.
Gilbert Ray Cisneros, Jr. disclosed buying AtriCure, Inc. (ATRC) on Aug 20, 2026, valued at $1,001 - $15,000.
Gilbert Ray Cisneros, Jr. disclosed selling AtriCure, Inc. (ATRC) on Sep 29, 2026, valued at $1,001 - $15,000.
From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.